TY  - CONF

T1  - CARDINALS: A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Utreloxastat (PTC857) in Patients with Amyotrophic Lateral Sclerosis (P5-11.010)

JO  - Neurology

UR  - http://dx.doi.org/10.1212/wnl.0000000000205241

PY  - 2024/04/09

AU  - Katz JS

AU  - Vu T

AU  - Chio A

AU  - McDermott C

AU  - Devos D

AU  - Johnston M

AU  - Sierra R

AU  - Tansy A

AU  - Trimmer J

AU  - Shefner JM

ED  - 

DO  - DOI: 10.1212/wnl.0000000000205241

PB  - Ovid Technologies (Wolters Kluwer Health)

VL  - 102

IS  - 17_supplement_1

Y2  - 2024/12/25

ER  -